Mechanism of Action (MOA) Animation
for Pharma and Biotech

It was designed with a dual audience in mind: on one hand, healthcare professionals who need to understand the mechanism of action precisely in order to explain it to their patients; on the other, a general audience interested in how the vaccine works. That dual purpose determines the level of technical detail and the pace of the narration, seeking a balance between scientific rigour and clarity.

The content is developed in direct collaboration with HIPRA’s scientific team, which validates every stage of the script: the structure of the recombinant protein, the role of the adjuvant and the immune response sequence being represented. No scene is considered final until the medical and pharmaceutical team confirms that it accurately reflects the real biological process, something that matters especially when the material may be used before regulatory agencies or in clinical contexts.

Yes. Once produced, the same mechanism of action animation can be adapted for medical congress presentations, training materials for medical sales representatives, social media content or explanatory resources aimed directly at patients, adjusting the length and the level of technical detail to the channel and the audience in each case.

It depends on how many biological phases need to be represented and on the level of molecular detail required. For a mechanism of action with several stages — recognition of the protein, response of the immune system and generation of immune memory, as in this case — the complete process, from scientific validation of the script to the final render, usually takes several weeks, with at least one round of review by the pharmaceutical team.

Although 3D animation does not replace the official technical and regulatory documentation of a drug or a vaccine, it can accompany it as supporting material for internal presentations, sales team training or scientific outreach, always making clear that it is an educational resource and not the approved data sheet of the product.

Every mechanism of action has its own biological logic — representing how a local anti-inflammatory works is not the same as showing how the immune system generates antibodies against a viral protein — so the scientific script and the level of molecular detail are adapted to each specific case, even though the production and validation process with the client’s scientific team follows a similar methodology across all the 3D for science projects we develop.

For non-clinical audiences such as investors or general media, the technical terminology is usually simplified without altering the underlying scientific content, relying more on the visual narrative of the process than on exact molecular nomenclature, so that the central message — how the vaccine protects the body — remains accurate and at the same time accessible to someone without biomedical training.

Yes, it is one of the most common uses once the project is finished: medical representatives can rely on short fragments of the animation during their visits to healthcare professionals, visually reinforcing an explanation that would otherwise depend only on the data sheet or on a verbal account, which speeds up the conversation and helps the message to be better retained.

If new relevant evidence about the mechanism of action appears, or the indication of the product is extended, the animation can be revised and updated selectively without rebuilding the whole project from scratch, as long as the base 3D model and the narrative structure remain valid, which reduces the cost and the time needed to maintain the material in the medium term.